Strategy

The main goal for the research at Department of Medical Genetics is to provide novel insights that both short term and long term improve diagnostics and treatment of patients with hereditary diseases (monogenic and complex/polygenic). To achieve this goal a key part of our strategy has been to stay on top of the unprecedented rapid changes in genetics and genomics driven by novel disruptive technologies within areas such as DNA sequencing, information and communications technology (ICT)/bioinformatics/machine learning and genome editing. An important, albeit challenging, task for AMG is to stay in front when it comes to adapting these technologies to the needs of our patients. 

Our strategy uses a multitude of approaches to achieve this: 

• Harvest synergies between research and diagnostics locally, nationally and internationally. 
• Foster a transdisciplinary culture of change and adaptability. 
• Secure cutting-edge competencies within relevant technologies. 
• Identify patient groups and clinical needs to direct our research to. 
• Educate medical students in medical genetics (different modules), physicians in training, specialising in medical genetics, MSc, PhDs and postdocs. 
• Maintain working environment with constant learning, development and fun at work. 
• Reflect the diversity of cultures and social conditions, race, ethnicity, gender, age, etc. 

To achieve these goals, we have been constantly seeking the best constellations, nationally and internationally, within each disease area, and secured active participation in Centers of excellence (SFFs), K.G. Jebsen centers, EU and NIH projects. Lectures and practical lab-courses are given and trainees at all levels are trained in our premises. Through these we have attempted to recruit the best experts at each level, who in turn have been successful in generating funding for their research This is a steady direction, which we will follow also in the years to come and in the new context of the Life Science Building.